Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) Debt to Equity (2017 - 2026)

Bioceres Crop Solutions' Debt to Equity history spans 10 years, with the latest figure at $0.8 for Q1 2026.

  • On a quarterly basis, Debt to Equity changed N/A to $0.8 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.8, a N/A change, with the full-year FY2025 number at $0.62, up 20.98% from a year prior.
  • Debt to Equity hit $0.8 in Q1 2026 for Bioceres Crop Solutions, up from $0.62 in the prior quarter.
  • Over the last five years, Debt to Equity for BIOX hit a ceiling of $0.92 in Q2 2022 and a floor of $0.51 in Q2 2024.
  • Historically, Debt to Equity has averaged $0.67 across 5 years, with a median of $0.62 in 2025.
  • Biggest five-year swings in Debt to Equity: tumbled 44.59% in 2023 and later grew 20.98% in 2025.
  • Tracing BIOX's Debt to Equity over 5 years: stood at $0.92 in 2022, then plummeted by 44.59% to $0.51 in 2023, then dropped by 0.05% to $0.51 in 2024, then rose by 20.98% to $0.62 in 2025, then increased by 29.78% to $0.8 in 2026.
  • Business Quant data shows Debt to Equity for BIOX at $0.8 in Q1 2026, $0.62 in Q2 2025, and $0.51 in Q2 2024.